http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2759047-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_985e586742507c77adffd57be9bc530e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10 |
| filingDate | 2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b154ee60838570af94e5108b0690283 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9251a02c80ed4fa183e31c92dbcc8175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14a8b346fa214f368488b584d9ceb42e |
| publicationDate | 2010-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2759047-A1 |
| titleOfInvention | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| abstract | This invention relates to novel compounds of the Formula Ik, Im1, Im2, Im5, In1, In2, 1o1, 1o2, 1o5, Ip1, Ip3, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 .beta.-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of Cortisol in a cell or the inhibition of the conversion of cortisone to Cortisol in a cell. |
| priorityDate | 2009-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1474.